Non-Competitive Combined/Synopsis for L-Glutamic Acid
Key Dates
Due Date
-
Posted Date
-
Agency & Value
Agency
NATIONAL INSTITUTES OF HEALTH OLAO
Contract Value
Not provided
Codes & Classification
Solicitation Number
75N98026Q01122
NAICS
325180 - Other Basic Inorganic Chemical Manufacturing
Classification Code
6810
Additional Details
The National Institutes of Health (NIH), Office of the Director, Office of Acquisitions, has issued a non-competitive combined synopsis/solicitation for the procurement of L-Glutamic Acid, specifically the Sigma-Aldrich Inc. 13C2 L-Glutamic Acid 2,4 99%, 1x1 gram. This acquisition is being conducted under the authority of FAR 12.603 for streamlined solicitation of commercial products or services and is not expected to exceed the simplified acquisition threshold. The procurement is authorized under 41 U.S.C. 1901 and FAR 6.302-3(a)(2)(ii), allowing for other than full and open competition due to the unique nature of the requirement.
The primary objective of this procurement is to support the Magnetic Resonance (MR) Spectroscopy Unit and Core at NIH, which is engaged in advanced in vivo carbon-13 (13C) spectroscopy research. The use of 13C-labeled chemicals, such as the specified L-Glutamic Acid, is critical for these studies because the natural abundance of 13C is only about 1%, rendering it undetectable without enrichment. The enriched 13C compound will enable the detection of brain metabolism and facilitate accurate measurement of key metabolites, thereby supporting neural science research across multiple groups within the National Institute of Mental Health (NIMH) and NIH at large. The absence of this chemical would significantly hinder the institute’s research capabilities in this domain.
The intended outcome is the successful delivery of the specified 13C2 L-Glutamic Acid to the NIH, NIMH, located at 10 Center Drive, Building 10, Bethesda, MD 20892. The contract will be awarded on a firm-fixed price basis to Sigma-Aldrich Inc., 3050 Spruce St., Saint Louis, Missouri 63103, as the only known source capable of providing the required product with the necessary specifications.
Key requirements for this procurement include:
- Supply of Sigma-Aldrich Inc. 13C2 L-Glutamic Acid 2,4 99%, 1x1 gram.
- Delivery to the specified NIH/NIMH location in Bethesda, Maryland.
- Compliance with all applicable Federal Acquisition Regulations (FAR) clauses and provisions, including those related to commercial items and System for Award Management (SAM) registration.
- Submission of detailed price quotations, including unit and list prices, shipping and handling costs, delivery timeframe, product/catalog numbers, and any other relevant information.
- Documentation demonstrating the offered product meets all salient characteristics.
The procurement is classified under NAICS code 325180 (Other Basic Inorganic Chemical Manufacturing), with a small business size standard of 1,000 employees. This requirement is not set aside for small business. The applicable Product Service Code is 6810.
The solicitation document incorporates all relevant provisions and clauses in effect through Federal Acquisition Circular (FAC) 2026-01 as of March 13, 2026. No additional contract requirements or terms and conditions beyond customary commercial practices have been identified. The Defense Priorities and Allocations System (DPAS) does not apply to this requirement.
Interested parties must submit responses electronically by September 8, 2026, at 10:00 AM EDT, referencing solicitation number 75N98026Q01122 / PCA-NIMH-04010. Submissions must be sent to [email protected] and include all required documentation, certifications, and evidence of capability to provide the specified product.
The primary point of contact for this procurement is Brian Lind ([email protected]), with Tonia Alexander ([email protected]) as the secondary contact. The notice remains active and can be accessed via the SAM.gov opportunity ID 79b58484f33b49bea86956827d0e734a.
This procurement represents a critical and specialized requirement for NIH’s ongoing neuroscience research and is intended to ensure continuity and advancement of scientific studies reliant on high-purity, isotopically labeled chemicals.